Literature DB >> 23725138

Effects of celecoxib on cycle kinetics of gastric cancer cells and protein expression of cytochrome C and caspase-9.

Yu-Jie Wang1, Xiao-Ping Niu, Li Yang, Zhen Han, Ying-Jie Ma.   

Abstract

OBJECTIVE: This investigation aimed to determine effects of celecoxib on the cell cycle kinetics of the gastric cancer cell line MGC803 and the mechanisms involved by assessing expression of cytochrome C and caspase-9 at the protein level.
METHODS: Cell proliferation of MGC803 was determined by MTT assay after treatment with celecoxib. Apoptosis was assessed using fluorescence staining and cell cycle kinetics by flow cytometry. Western blotting was used to detect the expression of caspase-9 protein and of cytochrome C protein in cell cytosol and mitochondria.
RESULTS: Celecoxib was able to restrain proliferation and induce apoptosis in a dose- and time- dependent manner, inducing G0/G1 cell cycle arrest, release of cytochrome C into the cytosol, and cleavage of pro-caspase-9 into its active form.
CONCLUSION: Celecoxib can induce apoptosis in MGC803 cells through a mechanism involving cell cycle arrest, mitochondrial cytochrome C release and caspase activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725138     DOI: 10.7314/apjcp.2013.14.4.2343

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

Review 1.  NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.

Authors:  Oluwafunke R Kolawole; Khosrow Kashfi
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

2.  Pathway analysis for drug repositioning based on public database mining.

Authors:  Yongmei Pan; Tiejun Cheng; Yanli Wang; Stephen H Bryant
Journal:  J Chem Inf Model       Date:  2014-02-05       Impact factor: 4.956

3.  Celecoxib exhibits an anti-gastric cancer effect by targeting focal adhesion and leukocyte transendothelial migration-associated genes.

Authors:  Guo-Hua Jin; Wei Xu; Yang Shi; Li-Bo Wang
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.